CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 58 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $23,934,000 | +77.4% | 3,296,752 | +58.9% | 0.00% | +33.3% |
Q3 2016 | $13,490,000 | +27.2% | 2,075,321 | +6.8% | 0.00% | +50.0% |
Q2 2016 | $10,607,000 | +40.5% | 1,942,735 | +20.4% | 0.00% | 0.0% |
Q1 2016 | $7,549,000 | -9.6% | 1,613,004 | -3.8% | 0.00% | 0.0% |
Q4 2015 | $8,349,000 | +37.4% | 1,676,506 | +3.7% | 0.00% | 0.0% |
Q3 2015 | $6,077,000 | -38.1% | 1,616,279 | -1.0% | 0.00% | 0.0% |
Q2 2015 | $9,816,000 | +17.9% | 1,633,218 | +9.8% | 0.00% | 0.0% |
Q1 2015 | $8,329,000 | +86.0% | 1,487,264 | -0.4% | 0.00% | +100.0% |
Q4 2014 | $4,479,000 | +28.2% | 1,492,901 | +14.5% | 0.00% | 0.0% |
Q3 2014 | $3,494,000 | -8.2% | 1,303,668 | -4.1% | 0.00% | 0.0% |
Q2 2014 | $3,805,000 | -41.4% | 1,359,091 | -8.7% | 0.00% | -50.0% |
Q1 2014 | $6,489,000 | +40.0% | 1,488,215 | +3.1% | 0.00% | +100.0% |
Q4 2013 | $4,634,000 | +93.1% | 1,443,635 | -4.3% | 0.00% | 0.0% |
Q3 2013 | $2,400,000 | +3.9% | 1,509,139 | +13.1% | 0.00% | 0.0% |
Q2 2013 | $2,309,000 | – | 1,334,451 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |